Cardinal Ebitda from 2010 to 2026

CLH Stock  EUR 180.75  8.60  4.54%   
Cardinal Health's EBITDA is decreasing over the last several years with slightly volatile swings. EBITDA is predicted to flatten to about 820.6 M. During the period from 2010 to 2026 Cardinal Health EBITDA regressed destribution of quarterly values had mean deviationof  1,083,244,488 and mean square error of 1601677.5 T. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
1.3 B
Current Value
820.6 M
Quarterly Volatility
1.5 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Cardinal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardinal Health's main balance sheet or income statement drivers, such as Discontinued Operations of 2.4 M, Interest Expense of 259.6 M or Selling General Administrative of 4.7 B, as well as many indicators such as . Cardinal financial statements analysis is a perfect complement when working with Cardinal Health Valuation or Volatility modules.
  
This module can also supplement various Cardinal Health Technical models . Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
The Ebitda trend for Cardinal Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cardinal Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Cardinal Health's Ebitda Growth Pattern

Below is the plot of the Ebitda of Cardinal Health over the last few years. It is Cardinal Health's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardinal Health's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Cardinal Ebitda Regression Statistics

Arithmetic Mean1,716,427,731
Coefficient Of Variation84.84
Mean Deviation1,083,244,488
Median1,423,000,000
Standard Deviation1,456,178,417
Sample Variance2120455.6T
Range5.7B
R-Value(0.54)
Mean Square Error1601677.5T
R-Squared0.29
Significance0.03
Slope(155,788,060)
Total Sum of Squares33927289.3T

Cardinal Ebitda History

2026820.6 M
20251.3 B
20221.4 B
202172 M
20201.3 B
2019-2.6 B
2018B

About Cardinal Health Financial Statements

Cardinal Health stakeholders use historical fundamental indicators, such as Cardinal Health's Ebitda, to determine how well the company is positioned to perform in the future. Although Cardinal Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cardinal Health's assets and liabilities are reflected in the revenues and expenses on Cardinal Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cardinal Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA1.3 B820.6 M

Currently Active Assets on Macroaxis

When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
It's important to distinguish between Cardinal Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardinal Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cardinal Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.